跳至主要内容
临床试验/CTRI/2025/11/097006
CTRI/2025/11/097006尚未招募不适用

Optimizing oncofertility:Evidence based protocols for cryopreservation of germ cells and gonadal tissue in adolescent cancer patients

SAR health line Pvt limited1 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2025年11月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
210
试验地点
1

研究概览

简要总结

Oncofertility involves the cryopreservation of germ cells and gonadal tissue but its efficacy to protect the germ cell from cancer affected patients is not clear due to interplay of critical factors during freeze and warming, such as cancer type, patient age, quality of germ cells and protocol employed. Despite advances and introduction of various adjuvants for cryoprotection gaps remain in techniques, access and clinical validation. Additionally, human sperm population in the ejaculate is highly heterogeneous rendering it extremely difficult to perform sperm selection for assisted reproduction. Due to precious nature of spermatozoa from cancer patients, we propose that additional cytological parameters may be considered to prevent iatrogenic damage to spermatozoa and to improve the effectiveness of sperm cryopreservation. Hence, it is imperative to better understand sperm physiology in men with cancer and to evaluate the effects of various steps in freezing. This will enable innovative strategies to define specific protocol to retain sperm functionality in cancer survivors. With this knowledge, new and effective evidence based ejaculate specific cryopreservation protocols can be designed.

研究设计

研究类型
Observational

入排标准

年龄范围
15.00 Year(s) 至 35.00 Year(s)(—)
性别
All

入选标准

  • Patients will be included across all cancer types and stage between 15 – 39 years of age based on the puberty onset and reproductive lifespan respectively and without any genetic disorders affecting fertility.

排除标准

  • The exclusion criteria include patients with known sex chromosome genetic disorders across all cancers.
  • Patients with relapse of cancer and who have undergone any gonadotoxic therapy prior to recruitment.

研究者

发起方
SAR health line Pvt limited
申办方类型
Other [private company]
责任方
Principal Investigator
主要研究者

Dr Satish Kumar Adiga

Kasturba Medical College

研究点 (1)

Loading locations...

相似试验